Now Enrolling For An Ankylosing Spondylitis Research Study!
Clinvest Research is currently enrolling patients 18 years or older who have been diagnosed with Ankylosing Spondylitis (AS). We are searching for people to enroll in a study testing the efficacy of an investigational drug.
Why Should You Participate?
Have you tried everything, and are still searching for a solution to Ankylosing Spondylitis? Clinvest is investigating a new option, but we need your participation to explore new horizons in health.
We are searching for Springfield area applicants to participate in a clinical research study to potentially improve options for sufferers. The goal of this study is to assess an investigational medication for Ankylosing Spondylitis. Medical research is designed to identify and provide solutions to medical conditions.
What Can You Expect?
The purpose of this study is to determine the benefit of taking 300mg of an investigational drug compared to the currently approved 150mg dose for patients with active, moderate to severe Ankylosing Spondylitis (AS). Qualified patients would come to our office for approximately 19 visits over a 52-week period. Patients will be given 16 doses of the investigational drug during the course of the study.
To Find Out More
Call Now (417) 883-7889
Not sure if you qualify? Simply call us today at (417) 883-7889, and our staff will be happy to answer any questions you may have.